Annual Cash & Cash Equivalents
$104.81 M
-$134.03 M-56.12%
31 December 2023
Summary:
Axonics annual cash & cash equivalents is currently $104.81 million, with the most recent change of -$134.03 million (-56.12%) on 31 December 2023. During the last 3 years, it has fallen by -$136.37 million (-56.54%).AXNX Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$239.45 M
+$70.83 M+42.01%
30 September 2024
Summary:
Axonics quarterly cash and cash equivalents is currently $239.45 million, with the most recent change of +$70.83 million (+42.01%) on 30 September 2024. Over the past year, it has increased by +$92.13 million (+62.54%).AXNX Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AXNX Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -56.1% | +62.5% |
| 3 y3 years | -56.5% | +4.7% |
| 5 y5 years | +6.6% | +214.1% |
AXNX Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | -56.5% | -16.8% |
Axonics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $239.45 M(+42.0%) |
| June 2024 | - | $168.62 M(-27.5%) |
| Mar 2024 | - | $232.65 M(+122.0%) |
| Dec 2023 | $104.81 M(-56.1%) | $104.81 M(-28.9%) |
| Sept 2023 | - | $147.32 M(+1.4%) |
| June 2023 | - | $145.34 M(-39.5%) |
| Mar 2023 | - | $240.10 M(+0.5%) |
| Dec 2022 | $238.85 M(+8.1%) | $238.85 M(-1.0%) |
| Sept 2022 | - | $241.33 M(+18.7%) |
| June 2022 | - | $203.24 M(-4.7%) |
| Mar 2022 | - | $213.18 M(-3.5%) |
| Dec 2021 | $220.88 M | $220.88 M(-3.5%) |
| Sept 2021 | - | $228.80 M(-1.0%) |
| June 2021 | - | $231.14 M(+76.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | $130.96 M(-45.7%) |
| Dec 2020 | $241.18 M(+41.0%) | $241.18 M(-10.4%) |
| Sept 2020 | - | $269.28 M(-6.4%) |
| June 2020 | - | $287.68 M(+80.0%) |
| Mar 2020 | - | $159.82 M(-6.6%) |
| Dec 2019 | $171.08 M(+74.0%) | $171.08 M(+124.4%) |
| Sept 2019 | - | $76.23 M(-7.8%) |
| June 2019 | - | $82.68 M(-7.4%) |
| Mar 2019 | - | $89.33 M(-9.1%) |
| Dec 2018 | $98.31 M(+302.9%) | $98.31 M(+387.9%) |
| Sept 2018 | - | $20.15 M(-18.5%) |
| June 2018 | - | $24.73 M(+1.4%) |
| Dec 2017 | $24.40 M(+197.2%) | $24.40 M |
| Dec 2016 | $8.21 M | - |
FAQ
- What is Axonics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Axonics?
- What is Axonics annual cash & cash equivalents year-on-year change?
- What is Axonics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Axonics?
- What is Axonics quarterly cash and cash equivalents year-on-year change?
What is Axonics annual cash & cash equivalents?
The current annual cash & cash equivalents of AXNX is $104.81 M
What is the all time high annual cash & cash equivalents for Axonics?
Axonics all-time high annual cash & cash equivalents is $241.18 M
What is Axonics annual cash & cash equivalents year-on-year change?
Over the past year, AXNX annual cash & cash equivalents has changed by -$134.03 M (-56.12%)
What is Axonics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of AXNX is $239.45 M
What is the all time high quarterly cash and cash equivalents for Axonics?
Axonics all-time high quarterly cash and cash equivalents is $287.68 M
What is Axonics quarterly cash and cash equivalents year-on-year change?
Over the past year, AXNX quarterly cash and cash equivalents has changed by +$92.13 M (+62.54%)